Get started
Author

Nwe Ni Than

Observed names: N N Than, N Than, N. N. Than, N. Than, N.N. Than, Nwe Ni (Sophia) Than, Nwe Than, Nwe-Ni Than, Than, Nwe
Observed institutions: National Health Service, The University of Sydney, University Hospitals Birmingham NHS Foundation Trust, Royal Free London NHS Foundation Trust, Barts Health NHS Trust, Queen Elizabeth Hospital Birmingham, Royal Prince Alfred Hospital, The Royal Free Hospital, Royal London Hospital, University Hospital Coventry, University Hospitals Coventry and Warwickshire NHS Trust, National Institute for Health and Care Research, NIHR Birmingham Liver Biomedical Research Unit, NIHR Birmingham Biomedical Research Centre, University of Birmingham
ORCID: 0000-0001-9432-5006
Observed ORCID: 0000-0001-9432-5006
OpenAlex ID: A5073720777
A concise review of non-alcoholic fatty liver disease
2015 · Nwe Ni Than, Philip N. Newsome · Atherosclerosis · 288
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial
2017 · Philip Noel Newsome, Richard Fox, et al. · ˜The œLancet. Gastroenterology & hepatology · 162
PDF
Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance
2015 · Sina Hübener, Ye Htun Oo, et al. · Clinical Gastroenterology and Hepatology · 106
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
2019 · Nwe Ni Than, James Hodson, et al. · JHEP Reports · 101
PDF
Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis
2017 · Andrew King, Diarmaid D. Houlihan, et al. · Gastroenterology · 65
PDF
Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy
2015 · Nwe Ni Than, Christiane Wiegard, et al. · Scandinavian Journal of Gastroenterology · 60
Liver abnormalities in pregnancy
2013 · Nwe Ni Than, James Neuberger · Best Practice & Research Clinical Gastroenterology · 48
Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease
2016 · Nwe Ni Than, Anwar Ghazanfar, et al. · QJM · 43
PDF
Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy
2016 · Nwe Ni Than, Hannah C. Jeffery, et al. · Canadian Journal of Gastroenterology and Hepatology · 39
PDF
REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial
2015 · A King, D Barton, et al. · BMJ Open · 31
PDF
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
2025 · Farah Abdelhameed, Attia Mustafa, et al. · Livers · 27
Stem cells for liver regeneration
2014 · N. N. Than, P. N. Newsome · QJM · 25
Non-alcoholic fatty liver disease: when to intervene and with what
2015 · Nwe Ni Than, Philip N Newsome · Clinical Medicine · 24
PDF
Cardiovascular Disease in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Comprehensive Narrative Review
2025 · Attia Mustafa, Chris Kite, et al. · International Journal of Molecular Sciences · 18
PDF
Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol
2016 · Nwe Ni Than, Claire L. Tomlinson, et al. · Systematic Reviews · 18
PDF
Poor correlation of 2D shear wave elastography and transient elastography in Fontan‐associated liver disease: A head‐to‐head comparison
2023 · Madeleine Gill, Sanjivan Mudaliar, et al. · JGH Open · 12
PDF
Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients
2016 · Nwe Ni Than, Doreen Koay Siew Ching, et al. · Hepatology International · 9
PDF
Rituximab treatment experience in patients with complicated type 1 autoimmune hepatitis in Europe and North America
2018 · N.N. Than, D. Schmidt, et al. · Journal of Hepatology · 7
Current Surveillance Strategy Is Less Effective for Detecting Early-Stage Hepatocellular Carcinoma in Patients with Non-Viral and Non-Cirrhotic Liver Disease
2025 · Jessica Spiers, Wenhao Li, et al. · Liver Cancer · 4
The Fatty Liver, Cirrhosis, and Liver Cancer Study (TENDENCY): Protocol for a Multicenter Case-Control Study
2023 · Yaqza Hussain, Ayman Bannaga, et al. · JMIR Research Protocols · 4
PDF
A Concise Review of Autoimmune Liver Diseases
2015 · Nwe Ni Than, Ye Htun Oo · InTech eBooks · 4
PDF
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus
2026 · Jeremy F Cobbold, Hamish Miller, et al. · ˜The œLancet. Gastroenterology & hepatology · 3
Corrigendum to “Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy”
2016 · Nwe Ni Than, Hannah C. Jeffery, et al. · Canadian Journal of Gastroenterology and Hepatology · 3
PDF
Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis
2025 · Farah Abdelhameed, Lukasz Lagojda, et al. · Frontiers in Endocrinology · 2
Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A General Overview and Approach in Clinical Practice
2023 · Nwe Than · Medical Research Archives · 2
PDF
Works count: 49
Citation count: 1,112
H-index: 15
I10-index: 16
Year
Topic
Type